Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02401867 · ClinicalTrials.gov registry record
Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients
A clinical trial of Sexually Transmitted Diseases and Uterine Cervical Neoplasms, sponsored by Fenway Community Health.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT02401867: Completed study of Sexually Transmitted Diseases and Uterine Cervical Neoplasms, sponsored by Fenway Community Health.
NCT02401867 is a study of Sexually Transmitted Diseases and Uterine Cervical Neoplasms that has completed, run by Fenway Community Health. The registered enrollment target is 150 participants, below the 1,247-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02401867, a study of Sexually Transmitted Diseases and Uterine Cervical Neoplasms, has completed, sponsored by Fenway Community Health.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the acceptability and effectiveness of utilizing vaginal self-swabs for HPV DNA testing as compared to provider-collected cervical swabs for HPV, as well as to investigate the prevalence of other Sexually Transmitted Infections (STIs) among sexually active female-to-male (FTM) transgender adults.
Primary Outcome
Quantitatively assessed the non-inferiority of vaginal self-swab for HPV DNA compared to provider-collected cervical swab for HPV via laboratory confirmed testing in sexually active FTM adults. Compared the concordance of the positive self-swab HPV DNA test results to the positive cervical provider swab HPV DNA test results (reference) using the McNemar's test, a two-sample test for binomial proportions for matched-pair data.
Conditions Studied
Study Locations (1)
Massachusetts
- Fenway Community Health - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-09 |
What the finished NCT02401867 record still lists
NCT02401867 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,247-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Sexually Transmitted Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT02401867 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02401867 about?
NCT02401867 is a clinical study titled "Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients". The purpose of this study is to assess the acceptability and effectiveness of utilizing vaginal self-swabs for HPV DNA testing as compared to provider-collected cervical swabs for HPV, as well as to investigate the prevalence of other Sexually Transmitted Infections (STIs) among sexually active fema...
What is the current status of trial NCT02401867?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2015-01. Estimated completion is 2016-09.
What conditions does trial NCT02401867 study?
This clinical trial studies the following conditions: Sexually Transmitted Diseases, Uterine Cervical Neoplasms.
Who is sponsoring clinical trial NCT02401867?
This trial is sponsored by Fenway Community Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02401867 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02401867's enrollment target sits among peer trials
150 25th of 35 higher than 11 of 35 other Sexually Transmitted Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexually Transmitted Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
RECRUITING · NA
-
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
RECRUITING · NA
-
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia